JEOL (6951) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 FY2025 was ¥36,354 million, up 26.8% year-over-year, with strong growth in operating and net income.

• Operating income rose to ¥4,075 million (up 291.0%), and net income attributable to shareholders was ¥3,896 million (up 125.9%).

• Growth was driven by robust demand in scientific and industrial equipment, while medical equipment sales were flat.

Financial highlights

• Gross profit increased to ¥18,199 million from ¥13,315 million year-over-year.

• Operating margin improved significantly, with operating income at ¥4,075 million versus ¥1,042 million last year.

• Comprehensive income for the quarter was ¥5,992 million, up 78.7% year-over-year.

• EPS for Q1 was ¥76.26, more than double the prior year’s ¥33.77.

Outlook and guidance

• Full-year revenue forecast remains at ¥183,000 million, up 5.0% year-over-year.

• Full-year operating income forecast is ¥30,000 million (up 9.0%), and net income forecast is ¥22,500 million (up 3.7%).

• No changes to previously announced guidance; sales and profits are expected to concentrate in Q4.